We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTUS
3626
DELISTED
Natus Medical Inc
NTUS
$27K ﹤0.01%
1,037
-1,148
-53% -$31.2K
BDSI
3627
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$27K ﹤0.01%
7,476
-2,598
-26% -$9.16K
MTL
3628
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$27K ﹤0.01%
12,977
-36,207
-74% -$74.1K
IHC
3629
DELISTED
Independence Holding Company
IHC
$27K ﹤0.01%
579
-33
-5% -$1.46K
QADA
3630
DELISTED
QAD Inc.
QADA
$27K ﹤0.01%
309
-1,340
-81% -$97.8K
ABUS icon
3631
Arbutus Biopharma
ABUS
$923M
$26K ﹤0.01%
8,606
+4,158
+93% +$12.9K
AGO icon
3632
Assured Guaranty
AGO
$3.31B
$26K ﹤0.01%
551
-19,470
-97% -$914K
ATEC icon
3633
Alphatec Holdings
ATEC
$1.45B
$26K ﹤0.01%
1,670
-1,385
-45% -$21.4K
BATRA icon
3634
Atlanta Braves Holdings Series A
BATRA
$3.49B
$26K ﹤0.01%
911
+65
+8% +$1.81K
BCS icon
3635
Barclays
BCS
$93.7B
$26K ﹤0.01%
2,740
-41,692
-94% -$426K
BLFS icon
3636
BioLife Solutions
BLFS
$1.7B
$26K ﹤0.01%
595
-674
-53% -$23.7K
BYSI icon
3637
BeyondSpring
BYSI
$32.5M
$26K ﹤0.01%
2,537
+1,094
+76% +$11.5K
CAC icon
3638
Camden National
CAC
$982M
$26K ﹤0.01%
536
-455
-46% -$21.6K
CBUS icon
3639
Cibus
CBUS
$145M
$26K ﹤0.01%
129
+82
+174% +$19.5K
CRD.A icon
3640
Crawford & Co Class A
CRD.A
$640M
$26K ﹤0.01%
2,869
-16
-0.6% -$158
DGII icon
3641
Digi International
DGII
$3.17B
$26K ﹤0.01%
1,288
-3,214
-71% -$60.4K
DHS icon
3642
WisdomTree US High Dividend Fund
DHS
$1.58B
$26K ﹤0.01%
331
-11,494
-97% -$907K
FLUX icon
3643
Flux Power
FLUX
$11.5M
$26K ﹤0.01%
2,175
+2,075
+2,075% +$22.6K
GOGO icon
3644
Gogo Inc
GOGO
$392M
$26K ﹤0.01%
2,294
-18,158
-89% -$210K
HROW icon
3645
Harrow
HROW
$1.48B
$26K ﹤0.01%
2,742
+205
+8% +$1.75K
IRON icon
3646
Disc Medicine
IRON
$3.12B
$26K ﹤0.01%
+134
New +$44.1K
KRNT icon
3647
Kornit Digital
KRNT
$815M
$26K ﹤0.01%
206
-653
-76% -$69K
NGNE icon
3648
Neurogene
NGNE
$714M
$26K ﹤0.01%
143
+62
+77% +$13.7K
OBK icon
3649
Origin Bancorp
OBK
$1.66B
$26K ﹤0.01%
602
-689
-53% -$29.9K
QSR icon
3650
Restaurant Brands International
QSR
$25.6B
$26K ﹤0.01%
401
-10,478
-96% -$706K
144 145
146
147 148

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.